β‐OHB treatment also impeded the progression of AD‐related phenotypes in ApoE‐deficient mice (Krishnan et al., 2020) and increased intermediates of the TCA cycle in the hippocampus of 3XTg AD mice (Pawlosky et al., 2017). The gene discussed is APOE; the disease is Alzheimer disease.